Medicure Stock Performance
| MPH Stock | CAD 0.98 0.01 1.01% |
The company secures a Beta (Market Risk) of -0.83, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Medicure are expected to decrease at a much lower rate. During the bear market, Medicure is likely to outperform the market. At this point, Medicure has a negative expected return of -0.0101%. Please make sure to verify Medicure's information ratio, downside variance, day typical price, as well as the relationship between the treynor ratio and kurtosis , to decide if Medicure performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Medicure has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Medicure is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors. ...more
Last Split Factor 1:15 | Last Split Date 2012-11-02 |
1 | MEDICURE TO PRESENT FINANCIAL RESULTS ON NOVEMBER 26, 2024 CALL at 830 AM ET FOR QUARTER ENDED SEPTEMBER 30, 2024 AND ANNOUNCES RESIGNATION OF BOARD MEMBER Form... | 11/18/2024 |
| Begin Period Cash Flow | 4.9 M | |
| Free Cash Flow | 1.8 M |
Medicure |
Medicure Relative Risk vs. Return Landscape
If you would invest 104.00 in Medicure on September 2, 2024 and sell it today you would lose (6.00) from holding Medicure or give up 5.77% of portfolio value over 90 days. Medicure is currently producing negative expected returns and takes up 4.202% volatility of returns over 90 trading days. Put another way, 37% of traded stocks are less volatile than Medicure, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Medicure Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medicure's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Medicure, and traders can use it to determine the average amount a Medicure's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0024
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MPH |
Estimated Market Risk
| 4.2 actual daily | 37 63% of assets are more volatile |
Expected Return
| -0.01 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Medicure is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Medicure by adding Medicure to a well-diversified portfolio.
Medicure Fundamentals Growth
Medicure Stock prices reflect investors' perceptions of the future prospects and financial health of Medicure, and Medicure fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Medicure Stock performance.
| Return On Equity | -0.13 | ||||
| Return On Asset | -0.0563 | ||||
| Profit Margin | (0.13) % | ||||
| Operating Margin | (0.22) % | ||||
| Current Valuation | 6.26 M | ||||
| Shares Outstanding | 10.44 M | ||||
| Price To Earning | 22.88 X | ||||
| Price To Book | 0.51 X | ||||
| Price To Sales | 0.49 X | ||||
| Revenue | 21.69 M | ||||
| Gross Profit | 12.71 M | ||||
| EBITDA | 1.32 M | ||||
| Net Income | (922 K) | ||||
| Cash And Equivalents | 45.7 M | ||||
| Cash Per Share | 3.07 X | ||||
| Total Debt | 544 K | ||||
| Debt To Equity | 0.70 % | ||||
| Current Ratio | 4.71 X | ||||
| Book Value Per Share | 1.91 X | ||||
| Cash Flow From Operations | 2.08 M | ||||
| Earnings Per Share | (0.20) X | ||||
| Market Capitalization | 10.33 M | ||||
| Total Asset | 28.06 M | ||||
| Retained Earnings | (65.85 M) | ||||
| Working Capital | 7.27 M | ||||
About Medicure Performance
Evaluating Medicure's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Medicure has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Medicure has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 137.38 | 130.51 | |
| Return On Tangible Assets | (0.06) | (0.06) | |
| Return On Capital Employed | (0.04) | (0.04) | |
| Return On Assets | (0.03) | (0.03) | |
| Return On Equity | (0.05) | (0.05) |
Things to note about Medicure performance evaluation
Checking the ongoing alerts about Medicure for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Medicure help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Medicure generated a negative expected return over the last 90 days | |
| Medicure has some characteristics of a very speculative penny stock | |
| Medicure has high historical volatility and very poor performance | |
| The company reported the revenue of 21.69 M. Net Loss for the year was (922 K) with profit before overhead, payroll, taxes, and interest of 12.71 M. | |
| About 27.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: MEDICURE TO PRESENT FINANCIAL RESULTS ON NOVEMBER 26, 2024 CALL at 830 AM ET FOR QUARTER ENDED SEPTEMBER 30, 2024 AND ANNOUNCES RESIGNATION OF BOARD MEMBER Form 6 K - Marketscreener.com |
- Analyzing Medicure's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Medicure's stock is overvalued or undervalued compared to its peers.
- Examining Medicure's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Medicure's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Medicure's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Medicure's stock. These opinions can provide insight into Medicure's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Medicure Stock Analysis
When running Medicure's price analysis, check to measure Medicure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicure is operating at the current time. Most of Medicure's value examination focuses on studying past and present price action to predict the probability of Medicure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicure's price. Additionally, you may evaluate how the addition of Medicure to your portfolios can decrease your overall portfolio volatility.